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INTRODUCTION
For the first time in 1998, the Korean Breast Cancer Society 
(KBCS) began a national status investigation to establish elem- 
entary resources regarding breast cancer in Korea for year 
1996. Since data was provided for 1997 and 1998, such inves-
tigations have been conducted every two years, and the char-
acteristics and changing trends of breast cancer in Korea have 
been made public [1-6]. Also, the KBCS developed a web-based 
breast cancer registration program in 2001 and they have util- 
ized it for a cancer registration project ever since. Using such   
a program, data have been collected and a national database 
established, through which various studies examining the char-
acteristics and changing patterns of breast cancers in Koreans 
have been performed. 
This study investigated the status and characteristics of breast 
cancer patients in Korea in 2008, and compared these results 
to those from 1996 and also to those internationally.
METHODS
The number of patients, ages, and genders at each hospital 
were surveyed in order to determine the total number of pa-
tients who had been newly diagnosed with breast cancer and 
treated throughout Korea from January 1st, 2008 to December 
31st, 2008.
The authors carried out a survey targeting 41 medical schools, 
general hospitals that had been designated as surgeon training 
hospitals by the Korean Surgical Society, and private hospitals 
and clinics specializing in breast disease. A questionnaire which 
was composed of the total number of patients, gender, and age 
group was forwarded to the physicians from each hospital.
Thirty-eight of the 41 medical schools (67 hospitals), 20 of 
the general hospitals, and 10 of the private hospitals and spe-
cial clinics participated in the survey, totaling 97 hospitals and 
clinics.
Detailed information other than that relating to the number 
of patients, age, and gender distributions were obtained from 
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Purpose: Since 1996, the Korean Breast Cancer Society has col-
lected nation-wide breast cancer data and analyzed the data using 
their online registration program biannually. The purpose of this 
study was to evaluate the characteristics of Korean breast can-
cer from 2008 and examine chronological based patterns. Meth-
ods: Data were collected from 38 medical schools (67 hospitals), 
20 general hospitals, and 10 private clinics. The data on the total 
number, gender, and age distribution were collected through a 
questionnaire as well as other detailed data analyzed via the online 
registration program. Results: In 2008, there were 13,908 patients 
who were newly diagnosed with breast cancer. The crude inci-
dence rate of female breast cancer was 57.3 among 100,000 
and the median age was 49 years. The age distribution had not 
changed since the initial survey; however the proportion of post-
menopausal patients had increased and median age was older 
than the past. In staging distribution, the proportion of early breast 
cancer (stage 0, I) was 47.2% with, breast-conserving surgery 
performed in 58% and mastectomy in 39.5%. Conclusion: Com-
pared to past data, the incidence of breast cancer in Korea con-
tinues to rise. Furthermore, the proportion of those detected by 
screening and breast conservation surgery has increased remark-
ably. To understand the patterns of Korean breast cancer, the na-
tion-wide data should continuously investigated.
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the 2008 resources from the KBCS’s breast cancer registration 
program. The items analyzed through the registration program 
included resources such as risk factors, clinical symptoms and 
physical findings, test findings (confirmation method of cancer 
diagnosis, pre-surgical blood test findings), surgical findings 
(surgery method, stage differentiation), pathological findings 
(stage, histological categorization, TNM stage, hormone recep-
tor, HER2) among others. The analysis target for crude inci-
dence, age, and gender distribution was 13,908 patients who 
had been treated for breast cancer in 2008. Other analyses were 
performed using the population from the online registration 
program. The number of patients analyzed was different de-
pending on each item.
Using the StatXact
® 9th version (Cytel Inc., Cambridge, USA) 
program, The Cochran Armitage test was done to assess trends 
related to changing patterns in menopausal status, clinical mani- 
festations, and histologic types. A p-values of less than 0.05 were 
considered statistically significant.
RESULTS
Head count, gender, and age distribution
The number of breast cancer patients who had been newly 
diagnosed in 2008 was 13,908 (Table 1). According to the type 
of hospitals, university hospitals were involved in 11,570 cases 
(83.2%), general hospitals in 1,632 (11.7%), and private clinics 
in 706 patients (5.1%). The youngest among the patients was 
13 years old, and the oldest was 92 years old, with a median 
age of 49 years. The age distribution of female patients was the 
highest in the 40s with 5,529 (39.8%), followed by the 50s with 
3,703 (26.7%), and the 30s and 60s. The number of male breast 
cancer patients was 49 (0.4%), with the 60s as the highest (n= 
17), followed by 50s (Table 1).
Clinical symptoms and physical findings
On examination of the symptoms of 6,672 patients registered 
in the online registration program in 2008, painless lump was 
found to be the highest with 3,526 cases (52.8%), followed by 
a lump with pain in 4.9%, and nipple discharge in 3.0%. The 
number of patients uncovered through regular screening was 
2,179 (32.6%) (Table 2). 
Risk factors
Patients who experienced menarche before 13 years of age 
comprised 18.9% of those registered in the online registration 
program, and those who experienced menopause after 55 years 
of age were 9.9%. The proportion of unmarried patients was 
5.3%, those with first childbirth before 30 years of age 15.3%, 
and those breast feeding 70.2%, those who were overweight 
with body mass index (BMI) over 25 comprised 29%, and those 
with a family history compared 7.7% (Table 3).
Diagnostic methods
The most popular method used to confirm the diagnosis of 
breast cancer was fine needle aspiration which was done in 
49.4% of cases; 42.2% of patients who had been diagnosed with 
Table 1. Age distribution
10-19 20-29 30-39 40-49 50-59 60-69 70-79 80- Total (%)
Female 9 198 1,850 5,529 3,703 1,826 643 101 13,859 (99.6)
Male 0 0 7 5 10 17 7 3       49 (0.4)
Total 9 198 1,857 5,534 3,713 1,843 650 104 13,908 (100)
% 0.1 1.4 13.4 39.8 26.7 13.2 4.7 0.7 100.0
Table 2. Clinical manifestations
Symptoms No. (%)
No symptom, detected on screening 2,179 (32.6)
Painless lump 3,526 (52.8)
Painful lump 326 (4.9)
Nipple discharge 203 (3.0)
Axillary mass 57 (0.9)
Skin change, retraction 64 (1.0)
Breast pain, discomfort 128 (1.9)
Nipple retraction 119 (1.8)
Others 70 (1.1)
Total 6,672 (100.0)
Table 3. Risk factors
Age of menarche 
No. (%)
Age of menopause
No. (%)
Age of first delivery
No. (%)
Obesity (BMI)
No. (%)
Family history
No. (%)
Marriage
No. (%)
Breast feeding
No. (%)
≤13  1,171 (18.9) ≤49     923 (43.2) ≤19   111 (2.1) <20     878 (11.9) Yes   535 (7.7)  6,929 
(94.7)
 4,348 (70.2)
14-20  5,009 (80.8) 50-54  1,002 (46.9) 20-24  1,583 (29.4) 20-25  4,356 (59.1)
>20     21 (0.3) ≥55   213 (9.9) 25-29  2,859 (53.2) 25-30  1,827 (24.8) No  6,419 (92.3)   384 (5.3)  1,844 (29.8)
≥30     825 (15.3) >30   311 (4.2)
Total 6,201 (100) 2,138 (100) 5,378 (100) 7,372 (100) 6,954 (100) 7,313 (100) 6,192 (100)Dataof2008:WhatIsDifferentfromthePast? 231
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ultrasound-guided fine needle aspiration, and 7.2% of those 
who had been diagnosed without the use of ultrasound (Table 
4). The diagnosis of 34.6% of patients was confirmed through 
core needle biopsy, and through excisional biopsy in 9.3%.
Surgery and staging
Among 7,195 patients whose surgical methods could be con-
firmed, lumpectomy with axillary lymph node dissection was 
the most common with 2,791 cases (38.8%), followed by mod-
ified radical mastectomy with 2,579 cases (35.8%) (Table 5). 
Breast conservation surgery, including segmentectomy and 
quadrantectomy in lumpectomy, was performed in 4,079 cases 
(58%), which was significantly higher than mastectomy (39.5%), 
implying that it was more frequently used. The number of pa-
tients whose stage could be classified was 7,206, 34.8% of whom 
were at stage I and the highest, followed by IIa at 25.4%, stage 
0 at 12.3%, IIb at 11.0%, and IIIa at 8.6% (Table 6).
With respect to surgical method per stage, 59.0%, 70.9%, 
and 59.3% of stages 0, I, and II, respectively, involved breast 
conservation surgery, which was conducted in 44.4% of         
stage III cases as well, confirming that the breast conservation 
surgery is widely used for advanced breast cancer as well (Ta-
ble 7).
Pathology
Among 6,659 patients whose pathologic results could be con-
firmed, invasive ductal carcinoma was the most common with 
5,616 cases (84.3%), followed by ductal carcinoma in situ (DCIS) 
in 790 (11.9%), and invasive lobular carcinoma in 151 (2.3%) 
(Table 8). Classified according to the World Health Organiza-
tion (WHO), invasive ductal carcinoma NOS was the most 
popular with 4,597 cases (85%), followed by invasive ductal car-
cinoma with an intraductal predominant type with 268 (5.0%), 
mucinous carcinoma with 176 (3.3%), papillary carcinoma with 
88 (1.6%), tubular carcinoma with 85 (1.6%), and medullary 
carcinoma with 46 (0.9%). The number of patients whose tu-
mor size could be confirmed was 7,206, 46.9% of whom were 
at T1 being the highest, followed by T2 at 33.9%, Tis at 12.2%, 
Table 4. Preoperative diagnostic methods
Methods Patients No. (%)
Fine needle aspiration  469 (7.2)
Excisional biopsy  602 (9.3)
Core needle biopsy 2,250 (34.6)
Incisional biopsy    71 (1.1)
USG guided biopsy (FNA) 2,744 (42.2)
Wire localization biopsy    57 (0.9)
Stereotactic biopsy    24 (0.4)
Frozen biopsy  239 (3.7)
Etc.    46 (0.7)
Total   6,502 (100.0)
USG=ultrasonography; FNA=fine needle aspiration.
Table 5. Operation methods
Methods No. (%)
Extended radical mastectomy      3 (0.1)
Radical mastectomy    27 (0.4)
Modified radical mastectomy 2,579 (35.8)
Simple mastectomy  232 (3.2)
Segmentectomy (lumpectomy)  396 (5.5)
Quardrantectomy with ALD    892 (12.4)
Lumpectomy with ALD 2,791 (38.8)
Biopsy    93 (1.3)
Etc.  182 (2.5)
Total   7,195 (100.0)
ALD=axillary node dissection.
Table 6. AJCC staging
Stage No. (%)
0    882 (12.2)
I 2,475 (34.3)
IIA 1,807 (25.1)
IIB    781 (10.8)
IIIA  614 (8.5)
IIIB    69 (1.0)
IIIC  366 (5.1)
IV  126 (1.7)
Others                      18 (0.2)
Unknown                      68 (0.9)
Total   7,206 (100.0)
AJCC=American Joint Committee on Cancer.
Table 7. Operation methods according to the stage
Mastectomy  BCO Biopsy, etc.
Stage 0    274 (31.1)    521 (59.0) 87 (9.9)
Stage I    658 (26.6) 1,755 (70.9) 62 (2.5)
Stage II 1,009 (39.0) 1,535 (59.3) 44 (1.7)
Stage III    573 (54.6)    466 (44.4) 10 (1.0)
Stage IV      74 (58.7)      50 (40.0)   2 (1.3)
BCO=breast conserving operation.
All values represent number (%).
Table 8. Histologic type
Histologic No. (%)
Ductal carcinoma in situ    790 (11.9)
Invasive ductal carcinoma 5,616 (84.3)
Lobular carcinoma in situ    20 (0.3)
Invasive lobular carcinoma 151 (2.3)
Paget’s disease (pure form)      4 (0.1)
Malignant phyllodes tumor    19 (0.3)
Lymphoma      3 (0.0)
Sarcoma      4 (0.1)
Others    49 (0.7)
Total   6,659 (100.0)232  YongSikJung,etal.
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T3 at 4.4%, and T4 at 2.2% (Table 9).
For nodal staging, N0 was the most common with 4,604 cases 
(64.7%), followed by N1 with 1,528 (21.5%), N2 with 574 (8.1%), 
and N3 with 412 (5.8%) (Table 10).
Biological marker
The proportions of estrogen and progesterone receptor ex-
pression were 66.9% and 59.5%. For the expression of c-erbB2, 
immunohistochemically negative cases were 52.2%, 1+ 16.6%, 
2+ 11.5%, and 3+ 19.7% (Table 11). According to the immu-
nohistochemical stain for p53, negative cases were 53.3%, 1+ 
19.8%, 2+ 7.8%, and 3+ 18.4% (Table 11).
Changing patterns of Korean breast cancer by year
Since 1996 when the KBCS announced the occurrence of 
breast cancer patients, the annual occurrence has continuous-
ly increased. The number of breast cancer patients in 2008 was 
13,908, which had increased by 23.4% from 11,275 in 2006, and 
was about 3.7 times greater than the number in 1996 (Figure 1). 
Calculation of the crude incidence rate of Korean female breast 
cancer cases in 2008, including carcinoma in situ yielded 57.3 
per 100,000, showing a significant increase from 46.8 in 2006. 
Among all breast cancers, infiltrating cancer showed 50.2 per 
100,000, and carcinoma in situ 7.1 per 100,000, thus confirming 
that the crude incidence rate was increasing for both (Figure 2).
The age specific crude incidence rate was the highest in the 
40s with 134.5 per 100,000, followed by 123.1 in the 50s, 89.2 
in the 60s, 45.7 in the 30s, and 44.9 in the 70s (Figure 3). The 
age specific incidence was similar to that in the past. The crude 
incidence rate increased evenly for all age groups; however, 
there were some differences in the degree of increment per age 
group. As for the 60s and 70s, the crude incidence rate increased 
by 3 times from 31.5 and 14.6 per 100,000 in 1998 to 89.2 and 
Table 9. TNM staging of tumor
T staging No. (%)
T0    34 (0.5)
Tis    867 (12.2)
T1 3,346 (46.9)
T2 2,417 (33.9)
T3  311 (4.4)
T4  160 (2.2)
Tx                      53
Others                      18
Total   7,206 (100.0)
Table 10. TNM staging of lymph node
N staging No. (%)
N0 4,604 (63.9)
N1 1,528 (21.2)
N2  574 (8.0)
N3  412 (5.7)
Nx    88 (1.2)
Total   7,206 (100.0)
Table 11. Biological marker
ER, No. (%) PR, No. (%)
Negative  2,177 (33.0) 2,657 (40.3)
Positive  4,417 (66.9) 3,929 (59.5)
Unknown       9 (0.1)    12 (0.2)
Total   6,603 (100.0)   6,598 (100.0)
p53, No. (%) c-erbB2, No. (%)
Negative  2,810 (53.3) 3,402 (52.2)
Weak (1+) 1,045 (19.8) 1,083 (16.6)
Intermediate (2+)  410 (7.8)    754 (11.5)
Strong (3+)    971 (18.4) 1,291 (19.7)
Unknown    34 (0.6)    12 (0.2)
Total    5,270 (100.0)   6,542 (100.0)
ER=estrogen receptor; PR=progesterone receptor.
Figure 2. Annual crude incidence of Korean female breast cancer. *Pa-
tients number per 100,000 women. 
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44.9 in 2008, respectively. The increment for the 30s was 2 times, 
and was 2.2 times for the 40s and 50s, showing that the increased 
rate of incidence was higher for older groups. Moreover, the 
median age was 49, which is slowly increased, and the ratio of 
menopausal females also slightly increased (p<0.001) (Table 12). 
With respect to diagnosis and treatment, cases where breast 
cancers were discovered without symptoms but rather through 
screening only comprised 32.6%, showing continuous increases 
every year (p<0.001) (Table 13), and the ratio of DCIS increased 
somewhat from 10.8% in 2006 to 11.9% (p<0.001) (Table 14). 
With regard to stage I breast cancer, however, the ratio decreased 
from 37.9% in 2006 to 34.8%, therefore, the ratio of early breast 
cancer (stages 0, I) decreased slightly (Figure 4). Regarding sur-
gical methods, breast conservation surgery was the most com-
mon with 58%, demonstrating that it was performed more than 
mastectomy for the first time (Figure 5).
Table 14. Histological types
Year 1996 1998 2000 2002 2004 2006 2008
DCIS    61 (4.9)    94 (5.6)  150 (6.5)  413 (7.4)  641 (9.6)    882 (10.8)    790 (11.9)
IDC 1,137 (91.4) 1,496 (89.2) 2,075 (89.3) 5,084 (88.8) 5,491 (82.2) 6,811 (84.0) 5,616 (84.3)
LCIS      3 (0.2)      3 (0.2)      3 (0.1)      8 (0.1)      9 (0.1)    16 (0.2)    20 (0.3)
ILC    31 (2.5)    39 (2.3)    58 (2.5)  123 (2.1)  131 (2.0)  185 (2.3)  151 (2.3)
Paget’s disease      6 (0.5)      9 (0.5)      4 (0.2)    18 (0.3)    14 (0.2)    11 (0.2)      4 (0.1)
Etc.      6 (0.5)    37 (2.2)    34 (1.5)    79 (1.4)    98 (1.5)  200 (2.5)    75 (1.1)
DCIS=ductal carcinoma in situ; IDC=invasive ductal carcinoma; LCIS=lobular carcinoma in situ; ILC=invasive lobular carcinoma.
Values represent number of patients (%).
Table 13. Clinical manifestation
Year 1996 1998 2000 2002 2004 2006 2008
Detect on screening 45 (5.0)    94 (7.9)  146 (7.7)    700 (12.9) 1,054 (17.4) 1,651 (23.8) 2,179 (32.6)
Symptomatic cancer 853 (95.0) 1,097 (92.1) 1,755 (92.3) 4,715 (87.1) 5,010 (82.6) 5,282 (76.2) 4,493 (67.4)
Values represent number of patients (%).
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Figure 3. Age specific crude incidence of Korean female breast cancer. 
*Patients number per 100,000 women. 
Table 12. Proportion of premenopausal patient
Year 1996 1998 2000 2002 2004 2006 2008
Premenopause, No. (%) 959 (63.8) 1,253 (61.3) 1,820 (62.3) 3,599 (57.9) 4,397 (60.7) 5,008 (56.9) 4,766 (54.9)
Postmenopause, No. (%) 545 (36.2)    792 (38.7) 1,102 (37.7) 2,615 (42.1) 2,844 (39.3) 3,788 (43.1) 3,920 (45.1)
Median age (yr) 46 46 46 47 47 48 49
Figure 4. Proportion of AJCC staging of Korean breast cancer. 
AJCC=American Joint Committee on Cancer. 
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DISCUSSION
In 1998, the KBCS announced and performed the first na-
tional research on breast cancers in Korea based on 1996 data. 
Since 2000, the society has announced the analytical resources 
regarding the occurrence and treatment status of breast cancers 
in Korea every two years. In 2001, in order to establish a nation-
al database for breast cancer patients, a special committee for 
the development of a breast cancer registration project was 
organized under the society, and an online registration pro-
gram was developed and is still in use today. 
The characteristics of breast cancers in Korea of 2008 indi-
cate a consistent increase in the incidence rate and the ratio of 
diagnosis through regular screening. At the time of investiga-
tion in 1996, there were 3,801 newly discovered breast cancer 
patients, followed by 4,695 in 1998, 5,401 in 2000, 7,551 in 2002, 
9,668 in 2004, 11,275 in 2006, and 13,908 in 2008.
For the last 12 years, the incidences have increased by more 
than 3.6 times, and by 2.9 times for 10 years after 1998, show-
ing consistent annual increase of greater than ten percent. The 
crude incidence rate, including carcinoma in situ, was 57.3 (in-
filtrating cancer 50.2) per 100,000, indicating that the rate in-
creased by 2.5 times from 20.3 in 1996. In the USA, the breast 
cancer incidence increased by 0.5% every year in the past; how-
ever, the age-standardized rate (ASR, 2000 US Std Population) 
of infiltrating breast cancer peaked at 141.2 per 100,000 in 1999, 
began to slowly decrease ever since, and dramatically dropped 
to 125.6 in 2003. It was found to be 124.7 per 100,000 in 2007 
[7]. The cause of such a decrease has been assumed to be the 
decreased use of hormone replacement therapy, suggested by 
the study results of Women’s Health Initiative Investigator (WHI) 
in 2002 [8,9]. Besides the USA, similar decreasing trends have 
been observed in the UK, Germany, France, Norway, Denmark, 
Australia, and New Zealand around the same period [10-14]. 
Further research is required to determine whether such a change 
is temporary or long-term, or whether it would occur in Asian 
countries.
According to GLOBOCAN 2008 [15], about 1.38 million 
people were diagnosed with breast cancer in 2008, which was 
in turn responsible for 23% of all cancers in females and 10.9% 
of all cancers. In Korea, resources from National Cancer Infor-
mation Center have indicated that breast cancer was respon- 
sible for 15.1% of female cancer in 2007, the highest frequency 
only behind thyroid cancer. In order to objectively compare the 
cancer incidence rates among countries, the ratio of the world 
standard population corresponding to each age group should 
be given as the weighted value, and then converted to the age-
standardized incidence rate. The age-standardized incidence 
rate of breast cancer in Korea in 2008 was 38.9 per 100,000. The 
country with the highest age-standardized incidence rate dur-
ing the same period was Belgium (109.4), with the USA at 72 
and, Asian countries such as Singapore, Taiwan, and Japan at 
59.9, 52.8, and 42.7 [15].
In the Western world, increases in age have been accompa-
nied with increased incidence rates of breast cancer. For exam-
ple, in USA, the median age of female breast cancer patients 
during the period between 2003 and 2007 was 61 years, and 
the age-specific incidence rate for those in their 40s was 153.5 
per 100,000 females, 235 for those in their 50s, 371.6 for those 
in their 60s, and 421.9 for those in their 70s, indicating that the 
incidence rate increased along with increases in age (Figure 6) 
[7]. In Korea, however, the median age in 2008 was found to 
Figure 6. Comparison of age-specific crude incidence rate. *Patients 
number per 100,000 women; 
†SEER 17 data (2003-2007); 
‡Cancer 
statistics in Japan (2008).
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be 49, which was slightly higher than 46 in 1996, but still more 
than a decade younger than that in USA. The age-specific in-
cidence rate in Korea was 134.5 per 100,000 for those in their 
40s, 123.1 for those in their 50s, 89.2 for those in their 60s, and 
44.9 for those in their 70s, again showing a decreasing trend 
along with the increasing age.
In Japan, the age-group distribution was similar to that of 
Korea in the past, however recent data showed that the inci-
dence rates in the 50s and 60s had increased, exhibiting a grad-
ual slope from the 40s to the 60s, and then slightly decreasing 
in the 70s, which was a different from that seen in Korea (Fig-
ure 6) [16].
The ratio of pre-menopausal females was maintained at 60% 
until 2004, however, following 56.9% in 2006, it dropped slight-
ly to 54.9%. Considering the fact that the median age slowly 
increased and the rate of post-menopausal breast cancer in-
creased over time, it would be plausible to expect similar move-
ment in age groups for Korea as those observed in Japan. As 
for the discovery of breast cancer, cases without symptoms but 
only with screening comprised only 6.4% in 1996, but increased 
by more than 5 times to 32.7% in 2008, indicating that general 
publicity and vitalization of screening program have been suc-
cessful to some extent. Furthermore, the stage 0 cancer has con-
stantly increased since 1996 and was 12.4% in 2008, being the 
highest among all past surveys, showing a positive result. On 
the other hand, however, the ratio of all early cancers (stages 0, 
I) in the per-stage classification was 45.2% in 2004, 47.5% in 
2006, and 47.2% in 2008 with no significant change. Therefore, 
the efficacy of breast screening needs to be evaluated in future 
investigations.
One of the noteworthy characteristics confirmed in the pres-
ent study was the fact that the ratio of breast conservation sur-
gery surpassed that of mastectomy. This ratio was only 18.7% 
in 1996; however, it has constantly increased since, reaching 
48.8% in 2006 and 58% in 2008, almost 20% higher than mas-
tectomy at 39.5%. According to surgical methods per stage, 
breast conservation surgery was 59% in stage 0, 70.9% in stage 
I, 59.3% in stage II, and 44.4% in stage III, showing that the rea-
son for the increase in breast conservation surgery was not sim-
ply the increase in the ratio of early breast cancers, but rather 
the increase in understanding of the surgeons regarding breast 
conservation surgical techniques, the increase in the desire for 
quality of life by patients, and the overall change in awareness 
through accumulated study results. 
The KBCS carried out a nation-wide survey regarding Korean 
breast cancer for 2008 using an offline questionnaire and an on-
line registration program. This study found that the incidence 
rate was constantly increasing and that the age distribution was 
similar to that previously reported. On the other hand, me- 
dian age, proportion of postmenopausal breast cancer patients, 
and incidence rate in older age groups increased. With respect 
to diagnosis and treatment, the detection of the cancer through 
screening increased markedly and the ratio of breast conser-
vation surgery surpassed that of mastectomy for the first time. 
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